+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Second International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkins lymphomas Report of the jury



Second International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkins lymphomas Report of the jury



Journal of Clinical Oncology 17(1): 423-429




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035702383

Download citation: RISBibTeXText


Related references

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. Annals of Oncology 10(1): 13-19, 1999

Phase II trial of rituximab as adjuvant therapy to high dose chemotherapy and peripheral blood stem cell transplantation for relapsed and refractory aggressive non-Hodgkins lymphomas. Blood 98(11 Part 1): 862a, November 16, 2001

HD-RI First results of a randomized trial comparing aggressive chemotherapy with high-dose therapy and hematopoietic stem cell transplantation in patients with chemosensitive relapse of Hodgkins disease. Blood 90(10 SUPPL 1 PART 1): 115A, Nov 15, 1997

Consensus conference on high-dose therapy with hematopoietic stem cell transplantation in diffuse large-cell lymphoma: Type of cells, optimal mobilization of stem cells - positive and negative selection. Annals of Oncology 9(Suppl 1): S23-S30, 1998

Consensus conference on high-dose therapy with hematopoietic stem cell transplantation in diffuse large-cell lymphoma. Type of cells, optimal mobilization of stem cells--positive and negative selection. Annals of Oncology 9 Suppl 1: S23-S30, 1998

Improved outcome with high-dose rituximab with G/GM-CSF and autologous stem cell transplantation for relapsed aggressive B-cell non-Hodgkins lymphomas The impact of histologies of follicular origin. Blood 102(11): 735a, November 16, 2003

High-dose therapy with peripheral blood stem cell transplantation in low-grade non-Hodgkins Lymphomas. Blood 88(10 SUPPL 1 PART 1-2): 120A, 1996

High-dose therapy with peripheral blood stem cell transplantation in patients with indolent non-Hodgkins lymphomas. Experimental Hematology (Charlottesville) 25(8): 848, 1997

High-dose therapy with peripheral blood stem cell transplantation in patients with low-grade non-Hodgkins lymphomas. Blood 92(10 SUPPL 1 PART 1-2): 460A, Nov 15, 1998

High dose therapy and hematopoietic stem cell transplantation in non-Hodgkin's lymphomas. Polskie Archiwum Medycyny Wewnetrznej 105 Suppl: 159-161, 2002

Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review. Biology of Blood and Marrow Transplantation 22(7): 1182-1196, 2016

Autologous hematopoietic stem cell transplantation following high-dose therapy for non-Hodgkins lymphoma in adults 60 years of age and older. Blood 94(10 SUPPL 1 PART 1): 170a, Nov 15, 1999

Autologous stem cell transplantation for aggressive non Hodgkins lymphomas responding to first line therapy. Blood 92(10 SUPPL 1 PART 1-2): 363B, Nov 15, 1998

High dose chemoradiotherapy with autologous hematopoietic stem cell transplantation in the treatment of advanced Hodgkins lymphoma: A report of 11 cases. Chinese Journal of Cancer Research 14(4): 254-258, 2002

Efficiency of in vivo purging with rituximab followed by high-dose therapy with autologous peripheral blood stem cell transplantation in B-cell non- Hodgkins lymphomas A single institution study. Blood 96(11 Part 1): 184a, November 16, 2000